Magnis Resources Shares Uplifted after Providing an Update on New York Battery Plant

On 5 October 2018, Magnis Resources Limited (ASX: MNS) provided an update regarding the progressive development of its New York Gigafactory. Several major developments have started to fast-track the New York Battery Plant into production. After the release of this news, the share price of the company increased by 1.493% as on 5 October 2018.

After the successful move of the battery manufacturing plant from North Carolina to New York, the work on process engineering and design have started along with the site preparations. Imperium3 (iM3) New York team, Equipment manufacturers and engineers are all working together to meet the production time frames. All environmental approvals and approval from local government are expected in the second quarter of 2019. Ex Tesla Senior Manager Mr. Chaitanya Sharma who is highly experienced in the lithium industry through his senior role at Lithium Americas Corporation has also joined the Imperium3 Advisory Board. A significant portion of the planned production has been presold through binding sales agreements to clients mainly in the automotive and renewables industry and further agreements are expected in the upcoming months. Many potential partners have held high-level discussions about involving with the New York battery plant through an investment. The board is going to assess all proposals as they are received and will update the market accordingly. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

Recently, the company signed a four-year party Joint Development Agreement with Dendrobium Automotive Limited, Charge CCCV LLC and Dendrobium Advanced Technologies Limited to develop the next generation high performing batteries. By progressively developing lithium-ion battery plants into production and aiming to source raw materials from projects such as the Company’s Nachu Graphite Project, the company is trying to unlock value through its multi-approach growth strategy.

In FY 2018, the company suffered a Net loss of $5.42 million which was a loss of $9.75 million in the previous year. The basic and diluted loss per share of the company decreased from 2.09 cents in FY 2017 to 0.97 cents in FY 2018. At the end of FY 2018, the company was having cash and cash equivalent of $1.52 million. Net cash used in operating activities was $5.07 million in FY 2018. MNS’s share traded at $0.340 at a market capitalization of $204.48 million as on 5 October 2018 (AEST 12:56 PM).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report